Aidian – Your aid in diagnostics We are a leading in vitro diagnostics (IVD) company established in 1974 in Finland. Specialising in point-of-care testing (POCT), we want to provide tools empowering healthcare professionals to make evidence-based diagnoses and treatment decisions. Our aim is to aid health globally by promoting efficient healthcare through accurate and fast diagnostics. We develop, manufacture, and distribute reliable and fast CE-marked diagnostic tests, especially for primary care. Our product portfolio includes solutions among others for infectious disease diagnostics, improved management of diabetes, and colorectal cancer screening. We provide solutions to fight against antimicrobial resistance (AMR), one of the biggest threats to global health, and drive sustainable use of antibiotics in primary care. In addition, we provide easy-to-use products for hygiene monitoring in hospitals and in industrial settings. Patient safety and high-quality products are at the heart of our business. Besides our headquarters in Finland, we have local offices in 12 countries, and our global footprint covers more than 60 countries. Our QMS is certified against IVDR and against ISO 13485:2016 Quality Management System standard and complies with FDA quality system requirements. For further information visit: www.aidian.eu or contact us through: www.aidian.eu/contact-us You can also follow us on: Facebook: facebook.com/AidianGlobal Instagram: @aidianglobal YouTube: @aidianglobal Products available in the USA: www.aidian.eu/us/products-available-in-the-usa Aidian's Privacy Policy: www.aidian.eu/privacy/privacy-statements
Looking for a particular Aidian employee's phone or email?
The Aidian annual revenue was $19.7 million in 2026.
Antti Koivula is the CEO (Interim) and CFO at Aidian of Aidian.
139 people are employed at Aidian.
The NAICS codes for Aidian are [5417, 54171, 541, 541713, 54].
The SIC codes for Aidian are [873, 87].